MiNK Therapeutics (INKT) Q2 2024 Earnings

14MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.19
-0.13
-0.06
-0

Details

Expected EPS
-0.1525
Actual EPS
-0.11
Surprise EPS
0.04
Surprise Percent
+27.87%

Description

MiNK Therapeutics (INKT) has reported earnings of -0.11 per share for Q2 2024.

0 Comments

Share your thoughts